Recent research has identified that tumor cells outcompete methionine in tumor microenvironment, thus hamper the methionine metabolism and intracellular levels of methionine of CD8 + T cells, resulting in the down-regulation of H3K79me2 and STAT5 for the eventually impaired T cell function [17]. Here, CD8A is linked to neoplasm.